Article
Biologic drugs have changed the lives of many psoriatic patients with severe disease, but the potential benefits offered by biotechnology are only beginning to be realized.
Combination of Abrocitinib and Dupilumab Effectively Treats Pediatric Atopic Dermatitis
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
Study Quantifies, Characterizes Health Care Burden of Prurigo Nodularis in England
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
Eyelashes: Hair Today, Gone Tomorrow
SkylineDx Data Confirms Accuracy of the Merlin Test for Low- and High-Risk Melanoma